Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram, a selective serotonin reuptake inhibitor, in healthy subjects

Authors
Category Primary study
ConferenceClinical Pharmacology in Drug Development
Year 2020
This article has no abstract
Epistemonikos ID: c14a2c4bbbc7d6c3fcb8ddec700ed11241cd0ce2
First added on: Apr 30, 2026